Nikko Asset Management Americas Inc. 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:38 pm Sale | 2024-09-30 | 13G | Twist Bioscience Corporation TWST | Nikko Asset Management Americas Inc. | 2,860,847 4.880% | -722,596 (-20.16%) | Filing |
| 2024-02-12 5:55 pm Purchase | 2023-12-31 | 13G | Twist Bioscience Corporation TWST | Nikko Asset Management Americas Inc. | 3,583,443 6.210% | 649,410 (+22.13%) | Filing |
| 2023-02-10 10:30 am Purchase | 2022-12-31 | 13G | Twist Bioscience Corporation TWST | Nikko Asset Management Americas Inc. | 2,934,033 5.180% | 2,934,033 (New Position) | Filing |